Safety and Tolerability of Deferoxamine Mesylate in Patients with Acute Intracerebral Hemorrhage

BACKGROUND AND PURPOSE: Treatment with the iron chelator, deferoxamine mesylate (DFO), improves neurological recovery in animal models of Intracerebral hemorrhage (ICH). We aimed to evaluate the feasibility, safety, and tolerability of varying dose-tiers of DFO in patients with spontaneous ICH, and...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Selim, Magdy, Yeatts, Sharon, Goldstein, Joshua N., Gomes, Joao, Greenberg, Steven, Morgenstern, Lewis B., Schlaug, Gottfried, Torbey, Michel, Waldman, Bonnie, Xi, Guohua, Palesch, Yuko
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2011
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3202043/
https://ncbi.nlm.nih.gov/pubmed/21868742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.111.617589
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg